PanGenomic Health (XCNQ:NARA) Gross-Profit-to-Asset % : 0.00% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. PanGenomic Health's annualized Gross Profit for the quarter that ended in Sep. 2024 was C$0.00 Mil. PanGenomic Health's average Total Assets over the quarter that ended in Sep. 2024 was C$0.06 Mil. Therefore, PanGenomic Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 0.00%.

PanGenomic Health Gross-Profit-to-Asset % Historical Data

The historical data trend for PanGenomic Health's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Gross-Profit-to-Asset % Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of PanGenomic Health's Gross-Profit-to-Asset %

For the Health Information Services subindustry, PanGenomic Health's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PanGenomic Health's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

PanGenomic Health Gross-Profit-to-Asset % Calculation

PanGenomic Health's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	0	/	( (0.504	+	0.071)	/ 2 )
	=	0	/	0.2875
	=	0.00 %

PanGenomic Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	0	/	( (0.062	+	0.063)	/ 2 )
	=	0	/	0.0625
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

PanGenomic Health Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

PanGenomic Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

LL3:Germany

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

Executives

Vincent Lum	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer
Kaidong Zhang	Senior Officer

PanGenomic Health Headlines

No Headlines